Literature DB >> 6752571

Effect of reimmunization with Fx1A late in the course of Heymann nephritis.

B Noble, J B Van Liew, J R Brentjens, G A Andres.   

Abstract

There is evidence that active immunologic injury to glomeruli and tubules does not continue into a late stage of Heymann nephritis. Support for that view has been provided by the results of a study of kidney immunopathology following reimmunization with Fx1A late in the course of the disease. An increased derangement of kidney function, observed after reimmunization, was related to changes detected in kidney morphology. The observation that immunologically mediated injury in Heymann nephritis may occur only during a limited period could have implications for our understanding of the pathogenesis of human membranous nephropathy.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6752571

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  8 in total

1.  Production of heterologous IgG antibody against Heymann nephritis antigen by injections of immune complexes.

Authors:  Arpad Z Barabas; Chad D Cole; Maria Sensen; Rene Lafreniere
Journal:  Int J Exp Pathol       Date:  2011-11-22       Impact factor: 1.925

Review 2.  Immunologically mediated lesions of kidney tubules and interstitium in laboratory animals and in man.

Authors:  J R Brentjens; B Noble; G A Andres
Journal:  Springer Semin Immunopathol       Date:  1982

Review 3.  Regaining tolerance to a self-antigen by the modified vaccination technique.

Authors:  Arpad Zsigmond Barabas; Chad Douglas Cole; Rene Lafreniere; Donald Mackay Weir
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

4.  Down-regulation of pathogenic autoantibody response in a slowly progressive Heymann nephritis kidney disease model.

Authors:  Arpad Z Barabas; Chad D Cole; Arpad D Barabas; Rene Lafreniere
Journal:  Int J Exp Pathol       Date:  2004-12       Impact factor: 1.925

5.  Production of Heymann nephritis by a chemically modified renal antigen.

Authors:  Arpad Z Barabas; Chad D Cole; Arpad D Barabas; Rene Lafreniere
Journal:  Int J Exp Pathol       Date:  2004-10       Impact factor: 1.925

6.  Urinary excretion of the C5b-9 membrane attack complex of complement is a marker of immune disease activity in autologous immune complex nephritis.

Authors:  C J Pruchno; M M Burns; M Schulze; R J Johnson; P J Baker; C E Alpers; W G Couser
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

7.  Somatic growth in corticosteroid-treated rats with passive Heymann nephritis--effects of recombinant human growth hormone on growth impairment.

Authors:  H Kawaguchi; M Hattori; M Kohno; K Ito; N Hizuka; K Takano
Journal:  Pediatr Nephrol       Date:  1991-09       Impact factor: 3.714

8.  Production of a new model of slowly progressive Heymann nephritis.

Authors:  Arpad Z Barabas; Chad D Cole; Arpad D Barabas; Rene Lafreniere
Journal:  Int J Exp Pathol       Date:  2003-12       Impact factor: 1.925

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.